Cover Kidney News
Volume/Issue:
Volume 13: Issue 10/11
Page:
66
Publication Date:
01 Oct 2021
Online Publication Date:
19 Oct 2021
  • Figure 1.
    View in gallery
    Figure 1.

    sFLT1 is a natural antagonist for vascular endothelial growth factor (VEGF)

Figure 1.

sFLT1 is a natural antagonist for vascular endothelial growth factor (VEGF)
  • 1.

    Wewers TM, et al. Circulating soluble Fms-like tyrosine kinase in renal diseases other than preeclampsia. J Am Soc Nephrol 2021; 32:1853–1863. doi: 10.1681/ASN.2020111579

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Bartlett CS, et al. Vascular growth factors and glomerular disease. Annu Rev Physiol 2016; 78:437–461. doi: 10.1146/annurev-physiol-021115-105412

Editorial Type:
Feature

Beyond Preeclampsia, Soluble FLT1 in Kidney Disease

Isaac Yang Isaac Yang and Tomokazu Souma are with the Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC.

Search for other papers by Isaac Yang in
Current site
Google Scholar
PubMed Close
and
Tomokazu Souma Isaac Yang and Tomokazu Souma are with the Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC.

Search for other papers by Tomokazu Souma in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 13: Issue 10/11
Publication Date:
01 Oct 2021
Page:
66
Restricted access
Save